Eradivir

About:

Eradivir is a biotech company that aims to develop a non-immunological targeting agent for use against the virus that causes COVID-19.

Website: https://www.eradivir.com

Top Investors: National Science Foundation, Biomedical Advanced Research and Development Authority (BARDA), Philip Low

Description:

Eradivir is a biotech company that aims to develop a non-immunological targeting agent for use against the virus that causes COVID-19. The company was founded in 2020 and is headquartered in West Lafayette, Indiana.

Total Funding Amount:

$11.1M

Headquarters Location:

West Lafayette, Indiana, United States

Founded Date:

2020-01-01

Contact Email:

info(AT)eradivir.com

Founders:

Isaac Barchas, Martin Low, Philip Low

Number of Employees:

1-10

Last Funding Date:

2024-09-23

IPO Status:

Private

Industries: